Showing 1 – 6 of 6 results.
Curated
Restricted
Arrestee Drug Abuse Monitoring II in the United States, 2012 (Restricted Use) (ICPSR 34821)
Released/updated on: 2013-08-29
Geographic coverage: New York City, Sacramento, United States, Chicago, Atlanta, Illinois, Colorado, Denver, California, Georgia, New York (state)
Time period: 2012-04-30--2012-07-29
The Arrestee Drug Abuse Monitoring II, 2012 is a collection of interview and bioassay data provided by over 3000 arrestees from five county sites within the United States. Under the sponsorship of the Office of National Drug Control Policy (ONDCP), the ADAM II program monitors drug use and related behaviors (treatment experiences, housing stability, drug market activity, age at first use, employment, etc.) in a probability based sample of male adult arrestees within 48 hours of their arrest. The five ADAM II sites for 2012 were: Atlanta, GA (Fulton County and the City of Atlanta); Chicago, IL (Cook County); Denver, CO (Denver County); New York, NY (Borough of Manhattan); and Sacramento, CA (Sacramento County). The 2012 survey represents the sixth year of ADAM II and includes data from 1,938 interviews and 1,736 urine tests that were conducted at the five ADAM II sites over a 21-day period, between April 30 and July 29, 2012. The samples from these sites were weighted to represent over 14,000 arrests of adult males in the five counties. ADAM II data include official records, arrestee responses from a 20-minute face-to-face interview, and results from voluntary urine samples which tested for the presence of nine different drugs. Identifying information on the arrestees was not retained or shared with law enforcement. Demographic variables include age, gender, race, arrest date and time, county of arrest, number and type(s) of offense(s), education, work status, and language of interview.
Curated
Restricted
Arrestee Drug Abuse Monitoring II in the United States, 2013 (Restricted Use) (ICPSR 35169)
Released/updated on: 2014-08-01
Geographic coverage: New York City, Sacramento, United States, Chicago, Atlanta, Illinois, Colorado, Denver, California, Georgia, New York (state)
Time period: 2013-05-05--2013-07-28
The Arrestee Drug Abuse Monitoring II, 2013 is a collection of interview and bioassay data provided by over 3000 arrestees from five county sites within the United States. Under the sponsorship of the Office of National Drug Control Policy (ONDCP), the ADAM II program monitors drug use and related behaviors (treatment experiences, housing stability, drug market activity, age at first use, employment, etc.) in a probability based sample of male adult arrestees within 48 hours of their arrest. The five ADAM II sites for 2013 were: Atlanta, GA (Fulton County and the City of Atlanta); Chicago, IL (Cook County); Denver, CO (Denver County); New York, NY (Borough of Manhattan); and Sacramento, CA (Sacramento County). The 2013 survey represents the seventh year of ADAM II and includes data from 1,900 interviews and 1,681 urine tests that were conducted at the five ADAM II sites over a 21-day period, between May 5, 2013 and July 28, 2013. ADAM II data include official records, arrestee responses from a 20-minute face-to-face interview, and results from voluntary urine samples which tested for the presence of nine different drugs. Identifying information on the arrestees was not retained or shared with law enforcement. Demographic variables include age, gender, race, citizenship, marital status, arrest date and time, county of arrest, number and type(s) of offense(s), education, work status, and language of interview.
Curated
Restricted
Arrestee Drug Abuse Monitoring Program II in the United States, 2007 (ICPSR 25821)
Released/updated on: 2010-01-28
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
Time period: 2007-04-01--2007-09-01
The Arrestee Drug Abuse Monitoring (ADAM) II program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, the ONDCP and Abt Associates have initiated a new data collection that replicates the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. A total of 8,296 arrestees were interviewed during the second and third quarters of 2007. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. The Arrestee Drug Abuse Monitoring (ADAM) II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated
Restricted
Arrestee Drug Abuse Monitoring Program II in the United States, 2008 (ICPSR 27221)
Released/updated on: 2010-03-31
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc. have initiated a new data collection that replicates the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implements two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collects data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. Data collection has been conducted across two back-to-back quarters in each of 10 counties from a county-based representative sample of 250 male arrestees per quarter for a total of 500 arrestees annually per site or a total of 5,000 arrestees across sites annually. A total of 7,717 arrestees were interviewed during the second and third quarters of 2008. Collection occurs in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2007 and ending March 31, 2008. Additional data collection periods were optioned by ONDCP, and subsequent cycles of back-to-back data collection (not yet available) began April 1, 2008. Participation is voluntary and confidential, and the procedures include a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated
Restricted
Arrestee Drug Abuse Monitoring Program II in the United States, 2009 (ICPSR 30061)
Released/updated on: 2011-02-24
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 7,794 arrestees were interviewed during the second and third quarters of 2009. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2009, and ending September 30, 2009. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated
Restricted
Arrestee Drug Abuse Monitoring Program II in the United States, 2010 (ICPSR 32321)
Released/updated on: 2011-11-04
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 8,332 arrestees were interviewed during the second and third quarters of 2010. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2010, and ending September 30, 2010. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.